Verastem Raises $32M In Second Round Of Financing
BOSTON (CBS) - Cambridge based bio-pharmaceutical start-up Verastem, has raised $32 million in just its second round of financing, as its promising cancer drug research continues.
Verastem plans to use the proceeds to support its research as it heads into clinical development as early as next year.
The former CEO of Genzyme Henri Termeer recently joined the board of Verastem.
WBZ's NewsRadio 1030's Anthony Silva talked with COO Robert Forrester
